跳到正文
穿戴裝置與測量科學橫斷面研究3 分鐘閱讀

Fitbit的睡眠、心率和步數規律對憂鬱篩查作用有限

MoveVitals 編輯部 · 研究發表 · 解讀更新

原文:Digital Biomarkers for Depression Screening With Wearable Devices: Cross-sectional Study With Machine Learning Modeling. · JMIR mHealth and uHealth · 2021 · 論文原文 ↗

先看重點

267名在職成年人連續14天佩戴Fitbit Charge 2,夜間心率波動更大、步數節律更不規律者憂鬱症狀更重,但在全部樣本中檢出能力有限。80%的準確率僅出現在把憂鬱者與無或極輕症狀者作對比的子樣本中,比真實篩查容易得多。

證據類型

橫斷面研究

解讀依據

公開摘要

閱讀重點

關聯與混雜

研究在問什麼

約半數憂鬱症患者未被診斷和治療,因此低成本、無打擾的篩查方式很有價值。作者檢驗了消費級穿戴式裝置測得的行為和生理資料(數字生物標誌物)能否識別在職族群的憂鬱風險。

研究對象與方法

橫斷面研究,共290名健康在職成年人,其中267人納入分析。參與者連續14天佩戴Fitbit Charge 2,並在基線和2週後完成健康問卷,包括9項患者健康問卷(PHQ-9)。研究者根據步數、心率、能量消耗和睡眠資料提取活動、睡眠和晝夜節律相關的生物標誌物。採用Spearman相關和多元迴歸分析關聯,並校正社會人口特徵、飲酒、吸菸、自評健康、主觀睡眠和孤獨感。監督式機器學習採用k折交叉驗證,在留出折上評估,並使用不同的PHQ-9臨界分數。

主要發現

以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。

  1. 1
    憂鬱症狀越重,凌晨2點至4點以及4點至6點的夜間心率波動越大,這一關聯較為穩健。
  2. 2
    症狀越重,基於步數的工作日晝夜節律越不規律(日間穩定性和自相關),每日步數峰值也越少。
  3. 3
    儘管有這些可靠的關聯,數字生物標誌物在全部樣本中檢出憂鬱的能力有限。
  4. 4
    在把憂鬱者與無或極輕症狀的健康者作對比的平衡子樣本中,模型識別高憂鬱風險者的準確率為80%,靈敏度為82%,特異度為78%。

限制與不確定性

  1. 1
    較高的準確率來自刻意對比的子樣本,排除了症狀處於中間程度的人,會高估在普通職場族群中的表現。
  2. 2
    樣本較小且較同質:平均年齡33歲,79.0%為華人,89.1%具有大學學歷,女性佔63.7%。
  3. 3
    憂鬱風險由自評問卷(PHQ-9)判定而非臨床診斷,且橫斷面設計無法說明先後順序。
  4. 4
    參與者只佩戴一種裝置、持續14天,結果未必適用於其他裝置或更長時間。本解讀僅基於摘要。

日常健康啟示

手環記錄的睡眠、心率和步數規律不能當作憂鬱檢測,本研究在一般族群中的檢出能力有限。研究發現的日常節律紊亂只是鬆散的訊號。如果你連續數週情緒低落或擔心自己的情緒,請諮詢臨床醫師,而不要依賴裝置資料。

如何連結自己的資料

本研究關注的正是夜間心率波動和每日步數節律的規律性這類資料。如果你想觀察,請使用同一裝置、保持相同的佩戴方式,看數週的趨勢,而不是單個夜晚。

如何理解這類證據

同一時期的測量通常不能確定方向或因果;症狀可能改變行為,不能只按行為導致症狀解釋。

作者的結構化摘要 English

以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。

Background

Depression is a prevalent mental disorder that is undiagnosed and untreated in half of all cases. Wearable activity trackers collect fine-grained sensor data characterizing the behavior and physiology of users (ie, digital biomarkers), which could be used for timely, unobtrusive, and scalable depression screening.

Objective

The aim of this study was to examine the predictive ability of digital biomarkers, based on sensor data from consumer-grade wearables, to detect risk of depression in a working population.

Methods

This was a cross-sectional study of 290 healthy working adults. Participants wore Fitbit Charge 2 devices for 14 consecutive days and completed a health survey, including screening for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), at baseline and 2 weeks later. We extracted a range of known and novel digital biomarkers characterizing physical activity, sleep patterns, and circadian rhythms from wearables using steps, heart rate, energy expenditure, and sleep data. Associations between severity of depressive symptoms and digital biomarkers were examined with Spearman correlation and multiple regression analyses adjusted for potential confounders, including sociodemographic characteristics, alcohol consumption, smoking, self-rated health, subjective sleep characteristics, and loneliness. Supervised machine learning with statistically selected digital biomarkers was used to predict risk of depression (ie, symptom severity and screening status). We used varying cutoff scores from an acceptable PHQ-9 score range to define the depression group and different subsamples for classification, while the set of statistically selected digital biomarkers remained the same. For the performance evaluation, we used k-fold cross-validation and obtained accuracy measures from the holdout folds.

Results

A total of 267 participants were included in the analysis. The mean age of the participants was 33 (SD 8.6, range 21-64) years. Out of 267 participants, there was a mild female bias displayed (n=170, 63.7%). The majority of the participants were Chinese (n=211, 79.0%), single (n=163, 61.0%), and had a university degree (n=238, 89.1%). We found that a greater severity of depressive symptoms was robustly associated with greater variation of nighttime heart rate between 2 AM and 4 AM and between 4 AM and 6 AM; it was also associated with lower regularity of weekday circadian rhythms based on steps and estimated with nonparametric measures of interdaily stability and autocorrelation as well as fewer steps-based daily peaks. Despite several reliable associations, our evidence showed limited ability of digital biomarkers to detect depression in the whole sample of working adults. However, in balanced and contrasted subsamples comprised of depressed and healthy participants with no risk of depression (ie, no or minimal depressive symptoms), the model achieved an accuracy of 80%, a sensitivity of 82%, and a specificity of 78% in detecting subjects at high risk of depression.

Conclusions

Digital biomarkers that have been discovered and are based on behavioral and physiological data from consumer wearables could detect increased risk of depression and have the potential to assist in depression screening, yet current evidence shows limited predictive ability. Machine learning models combining these digital biomarkers could discriminate between individuals with a high risk of depression and individuals with no risk.

來源與署名

Digital Biomarkers for Depression Screening With Wearable Devices: Cross-sectional Study With Machine Learning Modeling.

Rykov Y, Thach TQ, Bojic I, Christopoulos G, Car J.

JMIR mHealth and uHealth · 2021-10-25

DOI: 10.2196/24872 ↗PubMed · 34694233 ↗Europe PMC · 所記錄的開放授權: cc by ↗

摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。

MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱

來源查核日期 2026-11-01

實用健康指南

放在一起讀

·世代研究

加速度計處理方法不同,身體活動與中風、心肌梗死的關聯曲線也不同

在英國生物銀行中,基線無心血管疾病的90237名成年人追蹤至2022年12月,共發生1298例中風和2031例心肌梗死;中高強度身體活動(MVPA)與這兩種結局的關聯曲線形狀,取決於加速度計資料的處理方法。就中風而言,只有機器學習法得到直線下降的風險;就心肌梗死而言,機器學習法和LFENMO法呈曲線下降,活動計數法呈直線下降。摘要沒有給出風險比,只能說明不同方法的結論不一致,不能說明哪種方法更正確,而且這些只是觀察性關聯。

Preventive Medicine

重點論文精講閱讀論文 →
·測量驗證研究/回顧

智慧手錶資料能當「證人」嗎:心率驗證得最充分,其餘證據參差

一項圍繞數字取證展開的系統評價和統合分析,梳理了四大主流品牌智慧手錶的驗證研究,發現心率是研究最多、也最準確的指標。步數、距離、能量消耗、活動分類和睡眠的驗證不夠一致,結果因品牌、方案和報告方式而異。摘要沒有給出彙總資料,且多數研究是在健康族群中、於實驗室內完成的,所以無法說明某一塊手錶對某個人在日常生活中的表現。

Forensic Science International

重點論文精講閱讀論文 →
·回顧的回顧

活動追蹤器:每天多走約1800步,對其他健康指標影響較小

這項傘形綜述彙總了39篇系統評價和統合分析,涉及163992名參與者;結果顯示使用活動追蹤器與身體活動增加相關(標準化均數差SMD為0.3–0.6),相當於每天多走約1800步、多步行40分鐘,體重減輕約1公斤。對血壓、膽固醇、糖化血紅蛋白、生活質量和疼痛的影響通常很小,且多數不顯著。摘要沒有說明這些專案裡追蹤器還搭配了什麼,也沒有說明各評價之間重疊多少,因此不能把效果完全歸功於裝置本身。

The Lancet Digital Health

重點論文精講閱讀論文 →
·測量驗證研究/回顧

七款睡眠追蹤裝置:識別睡著很準,識別醒著和睡眠分期較差

在睡眠實驗室裡,34名健康的年輕成年人連續三晚佩戴七款消費級睡眠追蹤裝置中的若干款。與多導睡眠監測相比,所有裝置識別睡眠都很準(靈敏度均不低於0.93),但識別清醒較差(特異度0.18–0.54),七款中有五款與研究用活動記錄儀(特異度0.39)持平或更好;睡眠分期的估計結果不穩定。受試者是18至35歲的健康成年人,臥床時間固定為8小時,每款裝置只在其中11至20人身上測試,因此對有睡眠問題的人幾乎沒有參考價值。

Sleep

重點論文精講閱讀論文 →
穿戴裝置與測量科學 →